secwatch / observer
8-K filed September 4, 2024, 7:59 PM ET ticker BOLT CIK 0001641281
leadership confidence high sentiment neutral materiality 0.40

Bolt Biotherapeutics appoints Dr. Jakob Dupont to Board; two directors resign

Bolt Biotherapeutics, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jakob Dupont

Class II member of the Board
BOLT · Bolt Biotherapeutics, Inc.
Effective
2024-09-03
Filed
September 4, 2024, 7:59 PM ET
Effective September 3, 2024, the Board appointed Jakob Dupont, M.D., Ph.D., to serve as a Class II member of the Board.
Departed

Frank D. Lee

member of the Board
BOLT · Bolt Biotherapeutics, Inc.
Effective
2024-09-03
Filed
September 4, 2024, 7:59 PM ET
On September 1, 2024, Frank D. Lee notified the Company of his resignation as a member of the Board and the committees thereof, effective as of September 3, 2024.
Departed

James Healy

member of the Board
BOLT · Bolt Biotherapeutics, Inc.
Effective
2024-09-03
Filed
September 4, 2024, 7:59 PM ET
On August 28, 2024, James Healy, M.D., Ph.D., notified Bolt Biotherapeutics, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and the committees thereof, effective as of September 3, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jakob Dupont was appointed as Class II member of the Board at Bolt Biotherapeutics, Inc..

Action
appointed
Role
Class II member of the Board
Exact text from the filing
Effective September 3, 2024, the Board appointed Jakob Dupont, M.D., Ph.D., to serve as a Class II member of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Frank D. Lee resigned as member of the Board at Bolt Biotherapeutics, Inc..

Action
resigned
Role
member of the Board
Exact text from the filing
On September 1, 2024, Frank D. Lee notified the Company of his resignation as a member of the Board and the committees thereof, effective as of September 3, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

James Healy resigned as member of the Board at Bolt Biotherapeutics, Inc..

Action
resigned
Role
member of the Board
Exact text from the filing
On August 28, 2024, James Healy, M.D., Ph.D., notified Bolt Biotherapeutics, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and the committees thereof, effective as of September 3, 2024.
View on SEC.gov

Bolt Biotherapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-24-213225
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.